Client: Europe-based pharmaceutical company
Areas of operations: Global
Products: Vaccines, pharmaceuticals, nutritional products
Number of Employees: Over 80,000
Divesting a product portfolio augments financial agility, and enhances focus on manufacture and distribution of core brands.
The client decided to divest some assets and needed to put together an effective separation plan that entailed extensive planning, due diligence, and cautious execution in compliance with antitrust guidelines. The process required considerable resources to ensure successful divestment of brands and merger of the future commercial and legal entity while mitigating any risks to the companies and the end consumers.
For the tech separation, the client needed a partner with thorough understanding and experience of flawless delivery of IT work streams. The major requirements from the partner were to:
- Assess the impact of change to create and implement the simplest, most cost-effective solution with minimal impact to business for every tech work stream
- Support the buyer company with the implementation of core tech infrastructure and solutions
Wipro delivered migration roadmap across multiple tech work streams, such as Commercial ERP Customization, SAP Data Extraction and Migration, SharePoint and OneDrive Migration, and End User Computing Asset Transition.
Wipro prepared a thorough execution strategy to maximize performance, and save time and cost of delivery over a 2-year period across 30+ sites in India and Bangladesh markets.
Wipro team ensured commitment to delivery and attention to details in addition to driving efficiency, and effort and cost savings. Working as a team, Wipro helped the client realize their IT separation plans successfully ahead of the Transitional Service Agreement completion period
Highlights of Wipro’s execution across the tech work streams were: